Oleclumab
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Oleclumab (INN; development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers. This drug was developed by MedImmune/AstraZeneca.
Oleclumab (INN; development code MEDI9447) is a human monoclonal antibody targeting the ectonucleotidase CD73 that was designed for the treatment of pancreatic and colorectal and other cancers. This drug was developed by MedImmune/AstraZeneca.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1324061711 under CC BY-SA 4.0; modifications have been made.